Bicycle Therapeutics Plc (BCYC)
5.80
+0.18
(+3.20%)
USD |
NASDAQ |
Feb 25, 09:55
Bicycle Therapeutics Research and Development Expense (Quarterly) : 65.63M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 2.928M |
| Mereo BioPharma Group Plc | 4.243M |
| Autolus Therapeutics Plc | 27.72M |
| DBV Technologies SA | 26.82M |